These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3514776

  • 1. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW, Marder VJ.
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 4. A molecular model of plasmic degradation of crosslinked fibrin.
    Francis CW, Marder VJ.
    Semin Thromb Hemost; 1982 Jan; 8(1):25-35. PubMed ID: 6460319
    [Abstract] [Full Text] [Related]

  • 5. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B, Francis CW, Marder VJ.
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [Abstract] [Full Text] [Related]

  • 6. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ, Marder VJ.
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [Abstract] [Full Text] [Related]

  • 7. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.
    Francis CW, Marder VJ, Martin SE.
    Blood; 1980 Sep; 56(3):456-64. PubMed ID: 6447526
    [Abstract] [Full Text] [Related]

  • 8. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC, Lockhart MS, Taylor FB.
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [Abstract] [Full Text] [Related]

  • 9. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K, Nakamura M, Sunagawa M, Kosugi T.
    Haematologia (Budap); 2002 May; 32(4):457-65. PubMed ID: 12803119
    [Abstract] [Full Text] [Related]

  • 10. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB, Bradford TR, Littman BH, Wintroub BU.
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N, Davies A, Fletcher A.
    Thromb Haemost; 1977 Aug 31; 38(2):524-5. PubMed ID: 145666
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F, Haber E, Matsueda GR.
    Thromb Haemost; 1992 Mar 02; 67(3):335-40. PubMed ID: 1379385
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N, Kagiya H, Kumagai T, Kameko M, Tozuka M, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1990 Feb 02; 38(2):201-7. PubMed ID: 2329722
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
    Rowbotham BJ, Whitaker AN, Masci PP.
    Blood Coagul Fibrinolysis; 1990 Dec 02; 1(6):653-61. PubMed ID: 2133245
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.